Ophthalmology Times

… [Read more...] about Christine Kay, MD, on the 152-week results of the RESTORE study for retinitis pigmentosa

We ask leading experts in the field what eye disease they would cure and why. … [Read more...] about Part 6: What if? Curing any eye disease with the snap of your finger

Virtual Vision Health and VirtuaLens partner to enhance VR eye care tools, improving patient education and access to advanced diagnostic solutions. … [Read more...] about Virtual Vision Health and VirtuaLens enter partnership to accelerate virtual reality in eyecare

Klinge Biopharma partners with Horus Pharma to commercialize the Eylea biosimilar FYB203 in Europe, enhancing market reach and therapeutic options. … [Read more...] about Horus Pharma selected as additional commercialization partner for aflibercept biosimilar in Europe

A new staging system for diabetic retinopathy and macular edema is essential, integrating advanced imaging techniques for better disease management and patient outcomes. … [Read more...] about Q&A: Stela Vujosevic shares why the staging system for diabetic eye conditions should be updated